These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17925789)

  • 21. [The functions of calcium-sensing receptor in regulating mineral metabolism.].
    Kinoshita Y
    Clin Calcium; 2017; 27(4):491-497. PubMed ID: 28336824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacology of the extracellular calcium ion receptor].
    Ruat M
    Therapie; 2003; 58(5):395-401. PubMed ID: 14682186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathophysiology of primary hyperparathyroidism.
    Brown EM
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N24-9. PubMed ID: 12412774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Parathyroid gland, calcium receptor and calcimimetics].
    Ureña P
    Nephrologie; 2002; 23(4):151-64. PubMed ID: 12125321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Calcimimetic agents in the treatment of hyperparathyroidism secondary to chronic renal failure].
    Negri AL; Slatopolsky EA
    Medicina (B Aires); 2003; 63(2):165-71. PubMed ID: 12793088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium-Sensing Receptor Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1: Epitopes, Specificity, Functional Affinity, IgG Subclass, and Effects on Receptor Activity.
    Habibullah M; Porter JA; Kluger N; Ranki A; Krohn KJE; Brandi ML; Brown EM; Weetman AP; Kemp EH
    J Immunol; 2018 Dec; 201(11):3175-3183. PubMed ID: 30381479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization and function of the renal calcium-sensing receptor.
    Riccardi D; Valenti G
    Nat Rev Nephrol; 2016 Jul; 12(7):414-25. PubMed ID: 27157444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Basic and clinical aspects of calcimimetics. Structure and function of calcium-sensing receptor].
    Fukumoto S
    Clin Calcium; 2008 Jan; 18(1):32-6. PubMed ID: 18175869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of murine fetal-placental calcium metabolism by the calcium-sensing receptor.
    Kovacs CS; Ho-Pao CL; Hunzelman JL; Lanske B; Fox J; Seidman JG; Seidman CE; Kronenberg HM
    J Clin Invest; 1998 Jun; 101(12):2812-20. PubMed ID: 9637715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors.
    Rus R; Haag C; Bumke-Vogt C; Bähr V; Mayr B; Möhlig M; Schulze E; Frank-Raue K; Raue F; Schöfl C
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4797-803. PubMed ID: 18796518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium-sensing receptor activation in chronic kidney disease: effects beyond parathyroid hormone control.
    Massy ZA; Hénaut L; Larsson TE; Vervloet MG
    Semin Nephrol; 2014 Nov; 34(6):648-59. PubMed ID: 25498383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcimimetics and hyperparathyroidism.
    Krebs LJ
    Curr Opin Investig Drugs; 2004 Oct; 5(10):1080-5. PubMed ID: 15535429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics.
    Goodman WG; Quarles LD
    Kidney Int; 2008 Aug; 74(3):276-88. PubMed ID: 17568787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The calcium-sensing receptor and the hallmarks of cancer.
    Tennakoon S; Aggarwal A; Kállay E
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt B):1398-407. PubMed ID: 26608608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
    Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
    Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacology of AMG 416 (Velcalcetide), a novel peptide agonist of the calcium-sensing receptor, for the treatment of secondary hyperparathyroidism in hemodialysis patients.
    Walter S; Baruch A; Dong J; Tomlinson JE; Alexander ST; Janes J; Hunter T; Yin Q; Maclean D; Bell G; Mendel DB; Johnson RM; Karim F
    J Pharmacol Exp Ther; 2013 Aug; 346(2):229-40. PubMed ID: 23674604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cinacalcet upregulates calcium-sensing receptors of parathyroid glands in hemodialysis patients.
    Sumida K; Nakamura M; Ubara Y; Marui Y; Tanaka K; Takaichi K; Tomikawa S; Inoshita N; Ohashi K
    Am J Nephrol; 2013; 37(5):405-12. PubMed ID: 23594726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism.
    Hannan FM; Thakker RV
    Best Pract Res Clin Endocrinol Metab; 2013 Jun; 27(3):359-71. PubMed ID: 23856265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal hyperparathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q mutation: clinical benefit from cinacalcet.
    Reh CM; Hendy GN; Cole DE; Jeandron DD
    J Clin Endocrinol Metab; 2011 Apr; 96(4):E707-12. PubMed ID: 21289269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of the calcium sensing receptor in digestive physiology and pathophysiology (review).
    Xie R; Tang B; Yong X; Luo G; Yang SM
    Int J Oncol; 2014 Oct; 45(4):1355-62. PubMed ID: 25069966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.